BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 28, 2006
View Archived Issues
MK-0518 combination therapy yields HIV RNA reduction at 24 weeks
Read More
Novel antiarthritic compounds described in recent patents
Read More
Trimeris and Roche report on new potent fusion inhibitors with potential for once-weekly dosing
Read More
Insulin-stimulating properties of Hon-Chi reported
Read More
Targeting the pronociceptive action of CCK-8 for diabetes-induced peripheral sensitization
Read More
Novel treatment strategies for respiratory disorders claimed in recent patents
Read More
Ono patent discloses new compounds for treating HIV infection
Read More
ADA and EASD issue consensus statement on metformin treatment
Read More
Preliminary analysis from MEDAL program for Arcoxia
Read More
NeuroSearch to acquire Carlsson Research
Read More
CK-1827452 studied for oral administration
Read More
VivaGel studied for safety in men
Read More
Zileuton i.v. improves FEV1 in asthma patients
Read More
TPM-02/Insulin successfully delivers insulin across skin
Read More
Epigenetic targeting in psychopharmacology - a new avenue of research
Read More
KC-706 set to advance into phase II for inflammatory conditions
Read More
MGCD-0103 studied in phase II trial for relapsed or refractory Hodgkin's disease
Read More
NuPathe licenses LAD long acting delivery technology from U. of Pennsylvania
Read More
Dendreon submits sections of rolling BLA for Provenge
Read More
BrainStorm Cell Therapeutics to target stroke with adult stem cell technology
Read More
PXD-101 studied in aggressive B-cell lymphoma
Read More
GSK and ChemoCentryx establish strategic alliance in inflammatory disorders
Read More
Guanfacine extended release NDA filed for ADHD
Read More
ImmunoVaccine Technologies to use PADRE for vaccines
Read More
GlaxoSmithKline's Relenza approved in 15 E.U. countries
Read More